Galectin Therapeutics | GALT - 負債





負債 変化する 日付
AbbVie USD 72.86B 5.36B 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Gilead Sciences USD 22.17B 2.76B 2026-03
Immunic USD 0 0 2024-06
Incyte USD 38.27M 1.16M 2026-06
Merck USD 49.12B 222M 2026-03